In vitro gene transfer using human papillomavirus-like particles.
AUTOR(ES)
Touze, A
RESUMO
Recombinant papillomavirus-like particles have recently been shown to be highly effective for the prevention of papillomavirus infections and associated tumors, and a virus-like particle-based vaccine against the most prevalent HPV causing genital infection in humans will be developed in the near future. Another use of these virus-like particles may lie in gene therapy and DNA immunization. We report here that human papillomavirus-like particles composed of the major capsid protein (L1) of HPV-16 are able to package unrelated plasmid DNA in vitro and then to deliver this foreign DNA to eukaryotic cells with the subsequent expression of the encoded gene. The results indicate higher gene transfer than with DNA alone or with liposome. Virus-like particles are a very promising vehicle for delivering genetic material into target cells. Moreover, the preparation of the gene transfer vehicle is relatively easy.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=147398Documentos Relacionados
- Oral Immunogenicity of Human Papillomavirus-Like Particles Expressed in Potato
- Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies
- Papillomavirus-Like Particles Stimulate Murine Bone Marrow-Derived Dendritic Cells To Produce Alpha Interferon and Th1 Immune Responses via MyD88
- Proteins present in bovine papillomavirus particles.
- Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.
